In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cougar raises $47.5mm in PIPE

Executive Summary

Cougar Biotechnology (cancer therapeutics) raised $47.5mm through the private placement of 27.5mm units priced at $1.73 each. Each unit consisted of 0.9 shares of Cougar preferred stock and 0.1 shares of Cougar common stock. Cowen & Co. and Paramount BioCapital acted as the placement agents.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies